Article Details
Retrieved on: 2024-08-28 16:55:25
Tags for this article:
Click the tags to see associated articles and topics
Summary
A new mRNA-based vaccine, similar to the COVID vaccine, is undergoing its first trial in the UK to treat non-small-cell lung cancer. The technology aims to enhance immunotherapy outcomes and could revolutionize lung cancer treatment globally.
Article found on: www.medicalbrief.co.za
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here